Elevated plasma levels of adrenomedullin in congenital cyanotic heart disease
Muneo Yoshibayashi(National Cerebral and Cardiovascular Center), Kenji Kangawa(National Cerebral and Cardiovascular Center), Toshio Nishikimi(Kyoto University), Tetsuro Kamiya(National Cerebral and Cardiovascular Center), Yoshihiko Saito(National Center of Neurology and Psychiatry), Hisayuki Matsuo(National Cerebral and Cardiovascular Center)
Cited by 5
Related Papers
Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension
|Circulation|2000|880
Plasma Brain Natriuretic Peptide Levels Increase in Proportion to the Extent of Right Ventricular Dysfunction in Pulmonary Hypertension
|Journal of the American College of Cardiology|1998|578
The role of natriuretic peptides in cardioprotection
|Cardiovascular Research|2005|483
Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure.
|Journal of Clinical Investigation|1994|478
Increased plasma levels of adrenomedullin in patients with heart failure
|Journal of the American College of Cardiology|1995|307